Previous issue | Volume 89 | ESPE2018 | Next issue

57th Annual ESPE

Athens, Greece
27 Sep 2018 - 29 Sep 2018

Card image cap
ESPE 2018 57th European Society for Paediatric Endocrinology Annual Meeting 27-29 September 2018 Athens, Greece

Rapid Free Communications

Diabetes and Insulin 1

Diagnostics of Early Atherosclerosis Risk in Kids (DEAR-Kids): Retinal Vessel Analysis in Pediatric Type 1 Diabetes - Retinal Arteriolar Narrowing Caused By High HbA1c
aDepartment of General Paediatrics, Adolescent Medicine and Neonatology, Faculty of Medicine, Medical Centre, University of Freiburg, Freiburg, Germany; bChildrens Hospital Schwarzwald-Baar-Klinikum, Villingen-Schwenningen, Germany; cDivision of Preventive Sports Medicine and Systems Physiology, Department of Sport, Exercise and Health, University of Basel, Basel, Switzerland; dFaculty of Medicine, Institute for Exercise and Occupational Medicine, Medical Centre, University of Freiburg, Freiburg, Germany
hrp0089rfc3.1
Personalized and Predictive Medicine for Pediatric Diabetes Through a Genetic Test Using Next Generation Sequencing
aDepartment of Pediatrics, University Hospital of Geneva, Geneva, Switzerland; bFaculty of Medicine, Diabetes Center, University of Geneva, Geneva, Switzerland; cUniversity Hospital of Geneva, Geneva, Switzerland; dGenetic Medicine and Development, Faculty of Medicine, University of Geneva, Geneva, Switzerland
hrp0089rfc3.2
Significant Prevalence of Severe Monogenic Immune Defects Among Children with Type 1 Diabetes and Low T1D-Genetic Risk Score
aDepartment of Paediatrics, Second Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic; bInstitute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK; cDepartment of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic.
hrp0089rfc3.3
Functional Characterization of a Novel KLF11 Mutation Identified in a Family with Autoantibody-Negative Type 1 Diabetes
aNational Research Institute for Child Health and Development, Tokyo, Japan; bOsaka City University School of Medicine, Osaka, Japan; cHamamatsu University School of Medicine, Hamamatsu, Japan; dShikoku Medical Center for Children and Adults, Kagawa, Japan; eTokyo Women’s Medical University Medical Center East, Tokyo, Japan
hrp0089rfc3.4
Recent Secular Change in Pre- and Postnatal Growth and Adiposity in Infants of Mothers with Gestational Diabetes
aDepartment of Paediatrics, University of Cambridge, Cambridge, UK; bMRC Epidemiology Unit, University of Cambridge, Cambridge, UK
hrp0089rfc3.5
Treatment Adherence and Weight Loss are Key Predictors of HbA1c One Year after Diagnosis of Childhood Type 2 Diabetes in UK
aNIHR Biomedical Research Centre: Nutrition, Diet and Lifestyle theme, Bristol, UK; bMRC The Gambia at LSHTM, Fajara, Gambia; cPopulation Health Sciences, University of Bristol, Bristol, UK; dHelwan University, Helwan, Egypt; eRoyal College of Paediatrics and Child Health, London, UK; fInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK
hrp0089rfc3.6